drugset / Trial / NCT05309902

A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

NCT05309902

Phase 1 Withdrawn Takeda
RandomizedCrossoverQuadruple-blindOther

Summary

The main aim is to see if soticlestat has any effect in the heart rate. Participants will receive 4 doses of soticlestat in tablets and will complete some assessment which include to record activity of the heart and collection of blood samples. Then, the clinic will contact the participants 14 days after their final dose of soticlestat to check if they have any health problems.

Timeline

Start
2022-10-11
Primary completion
2022-12-06
Completion
2022-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule 400 mg Oral
Subject Soticlestat Small molecule 300 mg Oral
Subject Soticlestat Small molecule 900 mg Oral

Indications

No indication recorded.